Literature DB >> 9154827

The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.

Y Suzuki-Yagawa1, M Guermah, R G Roeder.   

Abstract

The general transcription initiation factor TFIID contains the TATA-binding protein (TBP) and TBP-associated factors (TAFs) implicated in the function of gene-specific activators. Previous studies have indicated that a hamster cell line (ts13) with a point mutation in the TAF(II)250/CCG1 (TAF(II)250) gene shows temperature-sensitive expression of a subset of genes and arrests in late G1 at 39.5 degrees C. Here, we report the identification of cell cycle-specific (G1-specific) genes that appear to be regulated directly through TAF(II)250 both in vivo and in vitro. Transcription rates of several cell cycle-regulatory genes were determined by run-on assays in nuclei from ts13 cells grown at permissive (33 degrees C) and nonpermissive (39.5 degrees C) temperatures. Temperature-dependent differences in transcription rates were observed for cyclin A, D1, and D3 genes. In transient-transfection assays, the human cyclin D1 promoter fused to a luciferase reporter showed a temperature-dependent reduction in activity in ts13 cells but not in parental BHK cells. In in vitro assays, upstream sequence-dependent transcription from the human cyclin D1 promoter was significantly reduced in ts13 nuclear extracts preincubated at 30 degrees C but not in similarly treated BHK nuclear extracts, and transcription in the ts13 extract was restored by addition of an affinity-purified human TFIID. Preincubation of the ts13 nuclear extracts did not affect the function of several GAL4-activation domain fusion proteins (GAL4-VP16, GAL4-p65, and GAL4-p53) on either the adenovirus major late or cyclin D1 core promoter bearing GAL4 sites, further indicating that the effect of the TAF(II)250 mutation is both core promoter and activator specific.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154827      PMCID: PMC232181          DOI: 10.1128/MCB.17.6.3284

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

Review 1.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

2.  Nuclear protein CBP is a coactivator for the transcription factor CREB.

Authors:  R P Kwok; J R Lundblad; J C Chrivia; J P Richards; H P Bächinger; R G Brennan; S G Roberts; M R Green; R H Goodman
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

3.  Human TAFII250 interacts with RAP74: implications for RNA polymerase II initiation.

Authors:  S Ruppert; R Tjian
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

4.  Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation.

Authors:  R D Klemm; J A Goodrich; S Zhou; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

5.  Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Authors:  M J Carrozza; N A DeLuca
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.

Authors:  C Albanese; J Johnson; G Watanabe; N Eklund; D Vu; A Arnold; R G Pestell
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

7.  Multiple TAFIIs directing synergistic activation of transcription.

Authors:  F Sauer; S K Hansen; R Tjian
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

8.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein.

Authors:  H Lu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.

Authors:  Z Shao; S Ruppert; P D Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex.

Authors:  J V Geisberg; J L Chen; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  36 in total

1.  Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.

Authors:  E L Dunphy; T Johnson; S S Auerbach; E H Wang
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Systematic analysis of essential yeast TAFs in genome-wide transcription and preinitiation complex assembly.

Authors:  Wu-Cheng Shen; Sukesh R Bhaumik; Helen C Causton; Itamar Simon; Xiaochun Zhu; Ezra G Jennings; Tseng-Hsing Wang; Richard A Young; Michael R Green
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome.

Authors:  Sara J Cooper; Nathan D Trinklein; Elizabeth D Anton; Loan Nguyen; Richard M Myers
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

4.  Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex.

Authors:  E Martinez; H Ge; Y Tao; C X Yuan; V Palhan; R G Roeder
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 5.  A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators.

Authors:  M Chang; J A Jaehning
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 6.  Considerations of transcriptional control mechanisms: do TFIID-core promoter complexes recapitulate nucleosome-like functions?

Authors:  A Hoffmann; T Oelgeschläger; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Region of yeast TAF 130 required for TFIID to associate with promoters.

Authors:  M Mencía; K Struhl
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

8.  Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt.

Authors:  Yongjun Yu; James C Alwine
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

Authors:  F Kashanchi; E T Agbottah; C A Pise-Masison; R Mahieux; J Duvall; A Kumar; J N Brady
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB.

Authors:  A Yamit-Hezi; R Dikstein
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.